The company have demonstrably advanced its course of a new solution for ATTR-CM, leveraging the compound. Preliminary trial information indicates potential improvements for those affected with the debilitating https://bridgebio036384.blogs-service.com/73278717/firm-advances-attr-cm-therapy-with-the-drug